首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1911847

獸藥市場規模、佔有率和成長分析（按產品類型、動物種類、給藥途徑、通路和地區分類）－2026-2033年產業預測

Veterinary Medicine Market Size, Share, and Growth Analysis, By Product Type (Pharmaceuticals, Vaccines), By Animal Type (Companion Animals (cats, dogs)), By Route of Administration, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月01日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球動物醫藥市場規模將達到 541.3 億美元，到 2025 年將達到 588.4 億美元，到 2033 年將達到 1146.9 億美元，預測期（2026-2033 年）的複合年成長率為 8.7%。

由於動物性蛋白質需求不斷成長、通用感染疾病發病率上升以及創新產品的推出，全球動物醫藥市場正經歷強勁成長。獸醫技術的進步和寵物保險的日益普及進一步推動了該行業的發展。聯邦政府資助的動物健康和福利項目的擴展，提高了消費者獲得必要服務的途徑，有助於改善動物福利和保障食品安全。這些努力有助於消除通用感染疾病，並促進永續農業實踐。世界各國政府建立的法規結構，確保了動物用藥品、疫苗和飼料添加劑的有效核准、生產和分銷，並保證其安全性、有效性和質量，從而增強了消費者對動物保健產品的信任和信心。

推動全球動物醫藥市場發展的因素

全球動物醫藥市場的主要驅動力是專科藥物、診斷技術和預防保健領域研發成本的不斷上漲。這一趨勢源於人們對寵物日益人性化的認知，以及飼主在寵物健康方面投入的不斷增加。隨著寵物獲得更先進的治療方案，例如疫苗、專科藥物和健康管理計劃，對這些產品的需求顯著成長。為了滿足這項需求，各公司正積極推動創新，例如生物製藥、偏好的口服寵物飼主。

全球動物醫藥市場面臨的限制因素

全球動物醫藥市場面臨許多限制因素，其中生物製藥和動物醫藥必須遵守嚴格的監管要求。這些法規因國家而異，其複雜性往往導致安全性和有效性評估的測試週期過長。這增加了研發成本，延長了產品上市時間。這種監管的不確定性通常對小規模公司不利，使它們難以參與競爭，並促使研發資源集中在大型公司手中。這阻礙了創新解決方案在農場和臨床環境中的應用，尤其是在基因療法和替代抗生素等領域。

全球動物醫藥市場趨勢

全球動物醫藥市場正經歷一場深刻的變革時期，而遠端醫療和數位科技的融合正是這場變革的驅動力。遠端醫療平台、遠端監測解決方案和人工智慧驅動的決策支援工具等創新技術正在改變獸醫服務的提供方式，尤其是在改善服務可及性和支援偏遠農村地區的畜牧養殖戶方面發揮著重要作用。數位化分診和電子處方箋能夠實現更積極主動的健康管理，而臨床記錄與預測分析相結合，則使獸醫能夠採用基於訂閱的醫療服務模式。這種模式不僅能夠提高依從性，還能創造穩定的收入來源，改善動物健康管理，並為更永續、更有效率的獸醫實踐鋪路。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Zoetis Inc.
Merck Animal Health（Merck & Co., Inc.）
Boehringer Ingelheim GmbH（Animal Health）
Elanco Animal Health Inc.
Ceva Sante Animale SA
Bayer AG（Animal Health division）
Vetoquinol SA
Nuproxa（or others）
Virbac SA
IDEXX Laboratories, Inc.
Dechra Pharmaceuticals plc（Animal Health）
Zoetis Pharmaceuticals Ltd.（companion unit）
Kyoritsu Seiyaku Corporation（Veterinary）
Huvepharma NV
SK Biopharmaceuticals（Veterinary segment）
Covetrus, Inc.
Hester Biosciences Ltd.
Kindred Biosciences, Inc.
Qilu Animal Health Company Ltd.
Vland Bioengineering Co., Ltd.

結論與建議

簡介目錄

Product Code: SQMIG35J2174

Global Veterinary Medicine Market size was valued at USD 54.13 Billion in 2024 and is poised to grow from USD 58.84 Billion in 2025 to USD 114.69 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global veterinary medicine market is experiencing robust growth driven by rising demand for animal protein, increasing instances of zoonotic diseases, and the introduction of innovative products. Advancements in veterinary practices, coupled with a growing trend in pet insurance, further support this sector. The expansion of federally funded animal health and wellness programs enhances consumer access to essential services, bolstering animal welfare and ensuring food supply safety. These initiatives lead to the culling of zoonotic pathogens and promote sustainable farming practices. Regulatory frameworks established by governments ensure the effective approval, production, and distribution of veterinary drugs, vaccines, and feed additives while guaranteeing their safety, efficacy, and quality, thereby fostering consumer trust and confidence in animal health products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Medicine Market Segments Analysis

Global Veterinary Medicine Market is segmented by Product Type, Animal Type, Route of Administration, Distribution Channel and region. Based on Product Type, the market is segmented into Pharmaceuticals, Vaccines, Medicated Feed Additives & Supplements and Diagnostics & Services (supportive). Based on Animal Type, the market is segmented into Companion Animals (cats, dogs, pets), Production / Livestock Animals (cattle, swine, poultry, aquaculture) and Others. Based on Route of Administration, the market is segmented into Injectable, Oral (tablets, powders), Topical & Spot-On and Feed-Based Additives. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, Online Pharmacies and Feed Mill / Livestock Supply Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Medicine Market

The Global Veterinary Medicine market is being significantly driven by the rising costs associated with the development of specialty medicines, diagnostics, and preventive care. This trend stems from the growing humanization of pets, leading owners to invest more in their animals' health. As pets increasingly receive advanced treatment options, including vaccines, specialty medications, and wellness programs, there is a noticeable surge in demand for these products. In response, companies are compelled to innovate, creating biologics and palatable oral medications, as well as subscription-based care models. Such advancements not only enhance revenue per patient but also strengthen the connection between pet owners and veterinary professionals.

Restraints in the Global Veterinary Medicine Market

The Global Veterinary Medicine market faces significant restraints due to the rigorous regulatory requirements that biologics and veterinary medicines must navigate, with these regulations differing across nations. This complexity often leads to protracted trial periods for assessing safety and efficacy, consequently increasing development costs and lengthening the time required to bring products to market. Such regulatory uncertainties tend to disadvantage smaller enterprises, causing them to struggle in competitive environments and causing research and development efforts to remain concentrated within larger corporations. As a result, the introduction of innovative solutions, particularly in areas like gene therapy and alternative antibiotics, is impeded in both farms and clinical settings.

Market Trends of the Global Veterinary Medicine Market

The Global Veterinary Medicine market is experiencing a significant shift propelled by the integration of telehealth and digital technologies. Innovations such as telemedicine platforms, remote monitoring solutions, and AI-driven decision-support tools are transforming veterinary care delivery, particularly benefiting underserved rural populations through enhanced accessibility. Digital triage and e-prescribing facilitate more proactive health management, while synchronized clinical records with predictive analytics empower veterinarians to implement subscription-based care models. This approach not only bolsters compliance but also generates reliable revenue streams, improving herd health management and paving the way for a more sustainable and efficient veterinary practice landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape

Global Veterinary Medicine Market Size by Product Type & CAGR (2026-2033)

Market Overview
Pharmaceuticals
Vaccines
Medicated Feed Additives & Supplements
Diagnostics & Services (supportive)

Global Veterinary Medicine Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Companion Animals (cats, dogs, pets)
Production / Livestock Animals (cattle, swine, poultry, aquaculture)
Others

Global Veterinary Medicine Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Injectable
Oral (tablets, powders)
Topical & Spot-On
Feed-Based Additives

Global Veterinary Medicine Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Veterinary Hospitals & Clinics
Retail Veterinary Pharmacies
Online Pharmacies
Feed Mill / Livestock Supply Channels

Global Veterinary Medicine Market Size & CAGR (2026-2033)

North America (Product Type, Animal Type, Route of Administration, Distribution Channel)
- US
- Canada
Europe (Product Type, Animal Type, Route of Administration, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Animal Type, Route of Administration, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Animal Type, Route of Administration, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Animal Type, Route of Administration, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health (Merck & Co., Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH (Animal Health)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Animal Health division)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuproxa (or others)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals plc (Animal Health)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Pharmaceuticals Ltd. (companion unit)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyoritsu Seiyaku Corporation (Veterinary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huvepharma NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SK Biopharmaceuticals (Veterinary segment)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covetrus, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hester Biosciences Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindred Biosciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qilu Animal Health Company Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vland Bioengineering Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments